Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting

25 Mar 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genetic factors in colorectal cancer
Share to Genomics and Rare Diseases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33765190
DOI: 10.1007/s10198-021-01293-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French settingPMID 33765190Read ↗

Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French studySemantic proximity Read ↗

Impact of Next-Generation Whole-Exome sequencing in molecular diagnosticsSemantic proximity Read ↗

Are whole Exome and whole Genome Sequencing Approaches Cost-Effective? A Systematic Review of the LiteratureSemantic proximity Read ↗

Evaluation of the diagnostic accuracy of exome sequencing and its impact on diagnostic thinking for patients with rare disease in a publicly funded health care system: A prospective cohort studySemantic proximity Read ↗

Reducing diagnostic turnaround times of exome sequencing for families requiring timely diagnosesSemantic proximity Read ↗

Exome and whole-genome sequencing as clinical tests: a transformative practice in molecular diagnostics.Semantic proximity Read ↗

Measuring coverage and accuracy of whole-exome sequencing in clinical contextSemantic proximity Read ↗

Clinical exome sequencing in daily practice: 1,000 patients and beyondSemantic proximity Read ↗

Impact of integrated translational research on clinical exome sequencingSemantic proximity Read ↗

Micro-costing Diagnostics in Oncology: From Single-Gene Testing to Whole Genome SequencingSemantic proximity Read ↗

Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencingSemantic proximity Read ↗

Regulating whole exome sequencing as a diagnostic testSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.